Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
US10940197B2 · kind B2 · utility
1Cited by
9References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 28, 2019 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | May 30, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16611
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.